In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 33 for your search:
Drug:  tivantinib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-A-U302, 2010-022365-10, NCT01244191

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-006, NCT01377376

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ197-A-U252, NCT01075048

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Enrolling by invitation
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-299, NCT01178411

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 anad over
Sponsor: Other
Protocol IDs: SCRI GI 157, NCT01611857

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 13 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-204, NCT00557609

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-205, NCT00558207

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-209, NCT00777309

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-215, NCT00988741

10.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-A-U251, NCT01055067

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 20 to 74
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-004, NCT01152645

12.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-218, NCT01395758

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03470, CDR0000712984, 2011-0197, 8984, U01CA062461, P30CA016672, N01CM00039, MDA-2011-0197, NCT01447914

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00237, CDR0000721410, OSU11132, 8986, U01CA062491, N01CM00071, N01CM00070, N01CM00100, P30CA016058, N01CM62207, NCT01519414

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00722, DFCI-12-017, CDR0000730102, 12-017, 8985, P30CA006516, U01CA062490, NCT01575522

16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-007, 23-4882, NCT01580735

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Closed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-01641, SWOG-S1107, S1107, U10CA032102, U10CA180888, NCT01688973

18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-01640, 478834, 12-1359, 9165, N01CM00038, N01CM00099, P30CA014599, N01CM00071, NCT01696955

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00937, 12-2158, 9267, N01CM00071, P30CA014599, NCT01861301

20.

Phase: Phase I
Type: Tissue collection/Repository
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-101, NCT00302172

21.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-0701, NCT00609921

22.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-103, NCT00612209

23.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-111, NCT00612703

24.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-114, NCT00802555

25.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ARQ 197-116, NCT00827177
1   
New Search